Chow, F. C. & Chok, K. S. Colorectal liver metastases: an update on multidisciplinary approach. World J. Hepatol. 27 (2), 150–172. https://doi.org/10.4254/wjh.v11.i2.150 (2019).
Google Scholar
Zeineddine, F. A. et al. Survival improvement for patients with metastatic colorectal cancer over twenty years. npj Precision Oncol. 7 (1), 16. https://doi.org/10.1038/s41698-023-00353-4 (2023).
Martin, J. et al. Colorectal liver metastases: current management and future perspectives. World J. Clin. Oncol. 24 (10), 761–808. https://doi.org/10.5306/wjco.v11.i10.761 (2020).
Google Scholar
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F. & Blumgart, L. H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230 (3), 309–318. https://doi.org/10.1097/00000658-199909000-00004 (1999). discussion 318 – 21.
Google Scholar
Malik, H. Z. et al. Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur. J. Surg. Oncol. 33 (8), 1003–1009. https://doi.org/10.1016/j.ejso.2007.01.005 (2007).
Google Scholar
Takahashi, S. et al. Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn. J. Clin. Oncol. 36 (6), 368–375. https://doi.org/10.1093/jjco/hyl027 (2006).
Google Scholar
Wong, G. Y. M. et al. Recurrence patterns predict survival after resection of colorectal liver metastases. ANZ J. Surg. 92 (9), 2149–2156. https://doi.org/10.1111/ans.17835 (2022).
Google Scholar
Creasy, J. M. et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery 163 (6), 1238–1244. https://doi.org/10.1016/j.surg.2018.01.004 (2018).
Google Scholar
Buisman, F. E. et al. Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment. Eur. J. Cancer 168, 25–33. https://doi.org/10.1016/j.ejca.2022.01.012 (2022).
Google Scholar
Van Cutsem, E. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 27 (8), 1386–1422. https://doi.org/10.1093/annonc/mdw235 (2016).
Google Scholar
Margonis, G. A., Andreatos, N. & Brennan, M. F. Predicting survival in colorectal liver metastasis: time for new approaches. Ann. Surg. Oncol. 27 (13), 4861–4863. https://doi.org/10.1245/s10434-020-09053-w (2020).
Google Scholar
Wang, Q. et al. Radiomics nomogram building from multiparametric MRI to predict grade in patients with glioma: A cohort study. J. Magn. Reson. Imaging 49 (3), 825–833. https://doi.org/10.1002/jmri.26265 (2019).
Google Scholar
Rogers, W. et al. Radiomics: from qualitative to quantitative imaging. Br. J. Radiol 93 (1108), 20190948. https://doi.org/10.1259/bjr.20190948 (2020).
Google Scholar
Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48 (4), 441–446. https://doi.org/10.1016/j.ejca.2011.11.036 (2012).
Google Scholar
van Timmeren, J. E., Cester, D., Tanadini-Lang, S., Alkadhi, H. & Baessler, B. Radiomics in medical imaging-how-to guide and critical reflection. Insights Imaging 12 (1), 91. https://doi.org/10.1186/s13244-020-00887-2 (2020).
Google Scholar
Li, H., Mendel, K. R., Lan, L., Sheth, D. & Giger, M. L. Digital mammography in breast cancer: additive value of radiomics of breast parenchyma. Radiology 291 (1), 15–20. https://doi.org/10.1148/radiol.2019181113 (2019).
Google Scholar
Cao, K. et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat. Med. 12 (12), 3033–3043. https://doi.org/10.1038/s41591-023-02640-w (2023). /01 2023.
Google Scholar
Selvam, M. et al. Radiomics as a non-invasive adjunct to Chest CT in distinguishing benign and malignant lung nodules. Sci. Rep. 4 (1), 19062. https://doi.org/10.1038/s41598-023-46391-7 (2023).
Google Scholar
Yu, Y. et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw. Open 1 (12), e2028086. https://doi.org/10.1001/jamanetworkopen.2020.28086 (2020).
Google Scholar
Park, H. et al. Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cance. Clin. Cancer Res. 1 (19), 4705–4714. https://doi.org/10.1158/1078-0432.Ccr-17-3783 (2018).
Google Scholar
Nie, K. et al. Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin. Cancer Res. 1 (21), 5256–5264. https://doi.org/10.1158/1078-0432.Ccr-15-2997 (2016).
Google Scholar
Jiang, Y. et al. Development and validation of a deep learning CT signature to predict survival and chemotherapy benefit in gastric cancer: a multicenter, retrospective study. Ann. Surg. 1 (6), e1153–e1161. https://doi.org/10.1097/sla.0000000000003778 (2021).
Google Scholar
Fiz, F. et al. Radiomics of liver metastases: a systematic review. Cancers (Basel) 7, 10. https://doi.org/10.3390/cancers12102881 (2020).
Karagkounis, G. et al. Computed tomography-based radiomics with machine learning outperforms radiologist assessment in estimating colorectal liver metastases pathologic response after chemotherapy. Ann. Surg. Oncol. 31 (13), 9196–9204. https://doi.org/10.1245/s10434-024-15373-y (2024).
Google Scholar
Chen, N., Zang, B. & Chen, Y. Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning. PLoS One. 20 (8), e0330828. https://doi.org/10.1371/journal.pone.0330828 (2025).
Google Scholar
Mian, A., Kamnitsas, K. & Gordon-Weeks, A. Radiomics for treatment planning in liver cancers. JAMA Surg. 160 (6), 708–709. https://doi.org/10.1001/jamasurg.2024.4346 (2025).
Google Scholar
Lakha, A. S. et al. Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study. Int. J. Surg. 1 (10), 3078–3086. https://doi.org/10.1097/js9.0000000000000557 (2023).
Google Scholar
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. Bmj 18, 385:q902. https://doi.org/10.1136/bmj.q902 (2024).
Nioche, C. et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 15 (16), 4786–4789. https://doi.org/10.1158/0008-5472.Can-18-0125 (2018).
Google Scholar
Aguirre-Meneses, H., Stoehr-Muñoz, P., Molina-Gonzalez, M., Nuñez-Gaona, M. A. & Roldan-Valadez, E. Radiomics and the Image Biomarker Standardisation Initiative (IBSI): a narrative review using a six-question map and implementation framework for reproducible imaging biomarkers. Cureus Oct. 17 (10), e95335. https://doi.org/10.7759/cureus.95335 (2025).
Google Scholar
Pudjihartono, N., Fadason, T., Kempa-Liehr, A. W. & O’Sullivan, J. M. A review of feature selection methods for machine learning-based disease risk prediction. Front. Bioinform. 2, 927312. https://doi.org/10.3389/fbinf.2022.927312 (2022).
Google Scholar
Sharma, A., Goyal, D. & Mohana, R. An ensemble learning-based framework for breast cancer prediction. Decis. Analytics J. https://doi.org/10.1016/j.dajour.2023.100372 (2024).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825– 2830 (2011).
Pölsterl, S. Scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J. Mach. Learn. Res. 21 (212), 1–6 (2020).
Cheng, J. et al. Prediction of histopathologic growth patterns of colorectal liver metastases with a noninvasive imaging method. Ann. Surg. Oncol. 26 (13), 4587–4598. https://doi.org/10.1245/s10434-019-07910-x (2019).
Han, Y. et al. Identification of predominant histopathological growth patterns of colorectal liver metastasis by multi-habitat and multi-sequence based radiomics analysis. Front. Oncol. 10, 1363. https://doi.org/10.3389/fonc.2020.01363 (2020).
Google Scholar
Sasaki, K. et al. Performance of two prognostic scores that incorporate genetic information to predict long-term outcomes following resection of colorectal cancer liver metastases: an external validation of the MD Anderson and JHH-MSK scores. J. Hepatobil. Pancreat. Sci.. 28 (7), 581–592. https://doi.org/10.1002/jhbp.963 (2021).
Google Scholar
Brudvik, K. W. et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann. Surg. 269 (1), 120–126. https://doi.org/10.1097/sla.0000000000002319 (2019).
Google Scholar
Wong, G. Y. M., Diakos, C., Molloy, M. P. & Hugh, T. J. Prognostic models incorporating RAS mutation to predict survival in patients with colorectal liver metastases: a narrative review. Cancers (Basel) 30, 13. https://doi.org/10.3390/cancers14133223 (2022).
Wang, W. et al. Prediction of KRAS gene mutations in colorectal cancer using a CT-based radiomic model. Front. Med. (Lausanne). 12, 1592497. https://doi.org/10.3389/fmed.2025.1592497 (2025).
Google Scholar
Lv, X. et al. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases. Eur. J. Radiol. Open 12, 100548. https://doi.org/10.1016/j.ejro.2024.100548 (2024).
Google Scholar
Kanno, H. et al. Prognostic significance of the histopathological growth pattern and tumor-infiltrating lymphocytes in stratifying survival after hepatectomy for colorectal liver metastases. Ann. Surg. Oncol.. 30 (5), 3139–3147. https://doi.org/10.1245/s10434-022-12905-2 (2023).
Google Scholar
Duffy, M. J. Tumor markers in clinical practice: a review focusing on common solid cancers. Med. Princ. Pract. 22 (1), 4–11. https://doi.org/10.1159/000338393 (2013).
Google Scholar
Dercle, L. et al. Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway. J. Natl. Cancer Inst. 1 (9), 902–912. https://doi.org/10.1093/jnci/djaa017 (2020).
Google Scholar
Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12 (1), 31–46. https://doi.org/10.1158/2159-8290.Cd-21-1059 (2022).
Google Scholar
Limkin, E. J. et al. The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features. Sci. Rep. 13 (1), 4329. https://doi.org/10.1038/s41598-019-40437-5 (2019).
Google Scholar
Ramón, Y. C. S. et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol. Med. (Berl) 98 (2), 161–177. https://doi.org/10.1007/s00109-020-01874-2 (2020).
Google Scholar
Galindo-Pumariño, C., Collado, M., Herrera, M. & Peña, C. Tumor microenvironment in metastatic colorectal cancer: the arbitrator in patients’ outcome. Cancers (Basel) 6, 5. https://doi.org/10.3390/cancers13051130 (2021).
Höppener, D. J. et al. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. Br. J. Cancer 123 (2), 196–206. https://doi.org/10.1038/s41416-020-0881-z (2020).
Google Scholar
Wei, S. et al. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics. Clin. Exp. Metastasis . 41 (2), 143–154. https://doi.org/10.1007/s10585-024-10275-5 (2024).
Google Scholar
Starmans, M. P. A. et al. Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp. Metastasis 38 (5), 483–494. https://doi.org/10.1007/s10585-021-10119-6 (2021).
Google Scholar
Wei, S. et al. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy. Eur. J. Radiol. 142, 109863. https://doi.org/10.1016/j.ejrad.2021.109863 (2021).
Google Scholar
Ormseth, B., Onuma, A., Zhang, H. & Tsung, A. The hepatic pre-metastatic niche. Cancers (Basel) 31, 15. https://doi.org/10.3390/cancers14153731 (2022).
Lin, Q. et al. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway. Cell Death Dis. 10(10), 693. https://doi.org/10.1038/s41419-019-1922-5 (2019).
Tang, S., Wu, J., Xu, S., Li, Q. & He, J. Clinical-radiomic analysis for non-invasive prediction of liver steatosis on non-contrast CT: a pilot study. Front. Genet. 14, 1071085. https://doi.org/10.3389/fgene.2023.1071085 (2023).
Google Scholar
Peloso, A., Tihy, M., Moeckli, B., Rubbia-Brandt, L. & Toso, C. Clearing steatosis prior to liver surgery for colorectal metastasis: a narrative review and case illustration. Nutrients 15, 24. https://doi.org/10.3390/nu14245340 (2022).
Yang, S., Peng, R. & Zhou, L. The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: a systematic review and meta-analysis. Front. Med. (Lausanne). 9, 938718. https://doi.org/10.3389/fmed.2022.938718 (2022).
Google Scholar
Zhou, H. et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal. Transduct. Target. Therapy. 03 (1), 70. https://doi.org/10.1038/s41392-022-00922-2 (2022).
Google Scholar
Reardon, D. A. & Wen, P. Y. Unravelling tumour heterogeneity—implications for therapy. Nat. Rev. Clin. Oncol. 12 (2), 69–70 (2015).
Google Scholar
Moosavi, S. H. et al. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity. Genome Med. 13 (1), 143. https://doi.org/10.1186/s13073-021-00956-1 (2021).
Montagnon, E. et al. Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis. PLoS One. 19 (9), e0307815. https://doi.org/10.1371/journal.pone.0307815 (2024).
Google Scholar
Orlhac, F. et al. How can we combat multicenter variability in MR radiomics? Validation of a correction procedure. Eur. Radiol. 31 (4), 2272–2280. https://doi.org/10.1007/s00330-020-07284-9 (2021).
Google Scholar
